secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001628280-24-015059
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals regains Nasdaq bid price compliance; deficiency notice closed
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Nov 13, 2023 for bid price below $1.00 for 30 consecutive trading days.
- On April 5, 2024, Nasdaq confirmed compliance with Bid Price Rule; matter now closed.
- Common stock (XFOR) remains listed on The Nasdaq Stock Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/0001628280-24-015059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/xfor-20240405.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-015059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer